News & Updates

Show Multimedia Only

Insulin glargine plus lixisenatide improves outcomes in Chinese adults with T2D

17 Dec 2025 by

Treatment with iGlarLixi* resulted in better clinical outcomes than IDegAsp** in Chinese adults with type 2 diabetes (T2D), regardless of age or disease duration at baseline, according to a post hoc analysis of the phase III Soli-D study presented at ATTD-ASIA 2025.

Insulin glargine plus lixisenatide improves outcomes in Chinese adults with T2D

17 Dec 2025

Add-on ON101 cost-effective for DFUs

16 Dec 2025 by

An economic analysis shows the cost-effectiveness of adding ON101 to general wound care (GWC) for the treatment of diabetic foot ulcers (DFUs) in individuals with type 2 diabetes (T2D) in Singapore, with robust results across subgroup and sensitivity analyses.

Add-on ON101 cost-effective for DFUs

16 Dec 2025

Eloralintide looks good for obesity

14 Dec 2025

Treatment with the novel selective amylin receptor agonist eloralintide results in substantial, dose-dependent reductions in bodyweight in adults with obesity, according to a phase II trial.

Eloralintide looks good for obesity

14 Dec 2025

Bedtime snacking may worsen T1D control in kids

12 Dec 2025

In young children with type 1 diabetes (T1D), bedtime snacking appears to result in higher nocturnal glucose values and reduced time in range (TIR), without decreasing the frequency of hypoglycaemia, according to a randomized controlled crossover trial.

Bedtime snacking may worsen T1D control in kids

12 Dec 2025

Semaglutide mitigates cardiometabolic burden in schizophrenia patients on second-gen antipsychotics

12 Dec 2025 by

Treatment with semaglutide appears to improve glycaemic control and weight outcomes in patients with schizophrenia receiving second-generation antipsychotics, as shown in a study.

Semaglutide mitigates cardiometabolic burden in schizophrenia patients on second-gen antipsychotics

12 Dec 2025

X-linked hypophosphataemia: Multidisciplinary care needed, targeted therapy effectively normalizes phosphate homeostasis

11 Dec 2025

Management of X-linked hypophosphataemia (XLH) has evolved in the past few years following the availability of burosumab, a fully humanized monoclonal antibody targeting circulating fibroblast growth factor 23 (FGF23), which has changed the landscape of XLH management, a panel of experts who spoke at EDM HK 2025 concurred.

X-linked hypophosphataemia: Multidisciplinary care needed, targeted therapy effectively normalizes phosphate homeostasis

11 Dec 2025

Does palmitoleic acid supplementation reduce hs-CRP in adults?

10 Dec 2025

Supplementation with palmitoleic acid (POA) 500 or 1,000 mg/day does not appear to substantially reduce high-sensitivity C-reactive protein (hs-CRP) or change other biomarkers in adults relative to placebo, reports a study.

Does palmitoleic acid supplementation reduce hs-CRP in adults?

10 Dec 2025

CGM cuts hospitalizations due to DKA, severe hypoglycaemia or hyperglycaemia crisis in young diabetes patients

08 Dec 2025 by

Continuous glucose monitoring (CGM) in young diabetes patients not only improves HbA_1c levels, but also substantially reduces hospitalizations due to diabetic ketoacidosis (DKA), severe hypoglycaemia or hyperglycaemia crisis, researchers from the Chinese University of Hong Kong (CUHK) have reported.

CGM cuts hospitalizations due to DKA, severe hypoglycaemia or hyperglycaemia crisis in young diabetes patients

08 Dec 2025

Oral corticosteroids confer little to no GDM risk for expectant mothers

05 Dec 2025 by

Exposure to oral corticosteroids during pregnancy is not associated with the risk of gestational diabetes mellitus (GDM), except for a modest increase during an early exposure window, as shown in a study from South Korea.

Oral corticosteroids confer little to no GDM risk for expectant mothers

05 Dec 2025

Does RAIT increase the risk of second primary malignancies in patients with PTC?

05 Dec 2025

In patients with papillary thyroid cancer (PTC), radioactive iodine therapy (RAIT) does not appear to increase the risk of a second primary malignancy (SPM), reports a study. On the other hand, age and personal or family history of cancer are predictive of SPM in this population.

Does RAIT increase the risk of second primary malignancies in patients with PTC?

05 Dec 2025

News & Updates

Showing Endocrinology articles

Showing

Specialty:

Insulin glargine plus lixisenatide improves outcomes in Chinese adults with T2D

Insulin glargine plus lixisenatide improves outcomes in Chinese adults with T2D

Add-on ON101 cost-effective for DFUs

Add-on ON101 cost-effective for DFUs

Eloralintide looks good for obesity

Eloralintide looks good for obesity

Bedtime snacking may worsen T1D control in kids

Bedtime snacking may worsen T1D control in kids

Semaglutide mitigates cardiometabolic burden in schizophrenia patients on second-gen antipsychotics

Semaglutide mitigates cardiometabolic burden in schizophrenia patients on second-gen antipsychotics

X-linked hypophosphataemia: Multidisciplinary care needed, targeted therapy effectively normalizes phosphate homeostasis

X-linked hypophosphataemia: Multidisciplinary care needed, targeted therapy effectively normalizes phosphate homeostasis

Does palmitoleic acid supplementation reduce hs-CRP in adults?

Does palmitoleic acid supplementation reduce hs-CRP in adults?

CGM cuts hospitalizations due to DKA, severe hypoglycaemia or hyperglycaemia crisis in young diabetes patients

CGM cuts hospitalizations due to DKA, severe hypoglycaemia or hyperglycaemia crisis in young diabetes patients

Oral corticosteroids confer little to no GDM risk for expectant mothers

Oral corticosteroids confer little to no GDM risk for expectant mothers

Does RAIT increase the risk of second primary malignancies in patients with PTC?

Does RAIT increase the risk of second primary malignancies in patients with PTC?